Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Boryung Pharmaceutical Co., Ltd., commonly referred to as Boryung, is a leading South Korean company specialising in pharmaceutical preparation manufacturing. Headquartered in Seoul, South Korea, the company operates across various regions, serving both domestic and international markets with a focus on innovative healthcare solutions. Established in 1950, Boryung has a long-standing history of advancing pharmaceutical development and production.
The company’s core business encompasses the manufacturing of prescription medicines, over-the-counter products, and biosimilars, distinguished by its commitment to quality and research-driven innovation. Boryung has earned a notable reputation for its robust product portfolio and strategic growth within the pharmaceutical industry. As a key player in South Korea’s healthcare sector, Boryung continues to expand its global footprint, maintaining a strong market position through dedication to excellence and patient-centric solutions.
-12 vs industry average
Boryung’s score of 30 is lower than 42% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Boryung, a Pharmaceutical Preparation Manufacturing company headquartered in KR, reported its Scope 2 emissions for 2023 at 343,000 kg CO2e. The company's Scope 1 and 2 emissions for 2023 totalled 27,457,000 kg CO2e.
In 2022, Boryung's Scope 2 emissions were 333,000 kg CO2e, with total Scope 1 and 2 emissions reaching 27,499,000 kg CO2e. For 2021, Scope 2 emissions were 299,000 kg CO2e, and combined Scope 1 and 2 emissions were 24,857,000 kg CO2e. In 2020, the company disclosed Scope 1 emissions of 3,906,000 kg CO2e and Scope 2 emissions of 22,623,000 kg CO2e, with a total of 26,482,000 kg CO2e for Scope 1 and 2. Emissions data for 2019 is not available. Boryung has not publicly reported any specific emissions reduction targets or commitments, such as those verified by the Science Based Targets initiative (SBTi). The company has not disclosed Scope 3 emissions for any reported year.
No climate goals have been disclosed for Boryung yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more